Literature DB >> 26990855

Granulocyte colony-stimulating factor impairs CD8(+) T cell functionality by interfering with central activation elements.

C E Bunse1,2, S Tischer1,2, J Lahrberg1, M Oelke3, C Figueiredo1, R Blasczyk1,2, B Eiz-Vesper1,2.   

Abstract

Besides mobilizing stem cells into the periphery, granulocyte colony-stimulating factor (G-CSF) has been shown to influence various types of innate and adaptive immune cells. For example, it impairs the effector function of cytotoxic T lymphocytes (CTLs). It is assumed that this effect is mediated indirectly by monocytes, regulatory T cells and immunomodulatory cytokines influenced by G-CSF. In this study, isolated G-CSF-treated CD8(+) T cells were stimulated antigen-dependently with peptide-major histocompatibility complex (pMHC)-coupled artificial antigen-presenting cells (aAPCs) or stimulated antigen-independently with anti-CD3/CD28 stimulator beads. By measuring the changes in interferon (IFN)-γ and granzyme B expression at the mRNA and protein level, we showed for the first time that G-CSF has a direct effect on CD8(+) CTLs, which was confirmed based on the reduced production of IFN-γ and granzyme B by the cytotoxic T cell line TALL-104 after G-CSF treatment. By investigating further elements affected by G-CSF in CTLs from stem cell donors and untreated controls, we found a decreased phosphorylation of extracellular-regulated kinase (ERK)1/2, lymphocyte-specific protein tyrosine kinase (Lck) and CD3ζ after G-CSF treatment. Additionally, miRNA-155 and activation marker expression levels were reduced. In summary, our results show that G-CSF directly influences the effector function of cytotoxic CD8(+) T cells and affects various elements of T cell activation.
© 2016 British Society for Immunology.

Entities:  

Keywords:  G-CSF; T cell activation; antigen-specific T cells; immunotherapy; mobilization

Mesh:

Substances:

Year:  2016        PMID: 26990855      PMCID: PMC4908295          DOI: 10.1111/cei.12794

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation.

Authors:  D Zeng; S Dejbakhsh-Jones; S Strober
Journal:  Blood       Date:  1997-07-01       Impact factor: 22.113

Review 2.  microRNAs function in CD8+T cell biology.

Authors:  Yan Liang; Hai-Feng Pan; Dong-Qing Ye
Journal:  J Leukoc Biol       Date:  2015-01-05       Impact factor: 4.962

Review 3.  Allogeneic transplantation: peripheral blood vs. bone marrow.

Authors:  William I Bensinger
Journal:  Curr Opin Oncol       Date:  2012-03       Impact factor: 3.645

4.  Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway.

Authors:  M Egerton; D R Fitzpatrick; A D Catling; A Kelso
Journal:  Eur J Immunol       Date:  1996-10       Impact factor: 5.532

5.  The EBMT activity survey 2009: trends over the past 5 years.

Authors:  H Baldomero; M Gratwohl; A Gratwohl; A Tichelli; D Niederwieser; A Madrigal; K Frauendorfer
Journal:  Bone Marrow Transplant       Date:  2011-02-28       Impact factor: 5.483

6.  Activation of the extracellular signal-regulated kinase pathway is differentially required for TCR-stimulated production of six cytokines in primary T lymphocytes.

Authors:  M Egerton; D R Fitzpatrick; A Kelso
Journal:  Int Immunol       Date:  1998-02       Impact factor: 4.823

7.  Hematopoietic stem cell mobilization with G-CSF induces innate inflammation yet suppresses adaptive immune gene expression as revealed by microarray analysis.

Authors:  Matthew P Buzzeo; Jie Yang; George Casella; Vijay Reddy
Journal:  Exp Hematol       Date:  2007-09       Impact factor: 3.084

8.  Peripheral-blood stem cells versus bone marrow from unrelated donors.

Authors:  Claudio Anasetti; Brent R Logan; Stephanie J Lee; Edmund K Waller; Daniel J Weisdorf; John R Wingard; Corey S Cutler; Peter Westervelt; Ann Woolfrey; Stephen Couban; Gerhard Ehninger; Laura Johnston; Richard T Maziarz; Michael A Pulsipher; David L Porter; Shin Mineishi; John M McCarty; Shakila P Khan; Paolo Anderlini; William I Bensinger; Susan F Leitman; Scott D Rowley; Christopher Bredeson; Shelly L Carter; Mary M Horowitz; Dennis L Confer
Journal:  N Engl J Med       Date:  2012-10-18       Impact factor: 91.245

9.  Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes.

Authors:  Keiko Morikawa; Shigeru Morikawa; Masahiko Nakamura; Toshio Miyawaki
Journal:  Br J Haematol       Date:  2002-07       Impact factor: 6.998

10.  Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.

Authors:  Bruno Salaun; Takuya Yamamoto; Bassam Badran; Yasuko Tsunetsugu-Yokota; Antoine Roux; Lukas Baitsch; Redouane Rouas; Hussein Fayyad-Kazan; Petra Baumgaertner; Estelle Devevre; Anirudh Ramesh; Marion Braun; Daniel Speiser; Brigitte Autran; Philippe Martiat; Victor Appay; Pedro Romero
Journal:  J Transl Med       Date:  2011-04-20       Impact factor: 5.531

View more
  8 in total

1.  Modulation of TAP-dependent antigen compartmentalization during human monocyte-to-DC differentiation.

Authors:  Marius Döring; Hanna Blees; Nicole Koller; Sabine Tischer-Zimmermann; Mathias Müsken; Frederik Henrich; Jennifer Becker; Elena Grabski; Junxi Wang; Hans Janssen; Werner Zuschratter; Jacques Neefjes; Frank Klawonn; Britta Eiz-Vesper; Robert Tampé; Ulrich Kalinke
Journal:  Blood Adv       Date:  2019-03-26

2.  T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells.

Authors:  Anthony M Battram; Aina Oliver-Caldés; Maria Suárez-Lledó; Miquel Lozano; Miquel Bosch I Crespo; Núria Martínez-Cibrián; Joan Cid; David F Moreno; Luis Gerardo Rodríguez-Lobato; Alvaro Urbano-Ispizua; Carlos Fernández de Larrea
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-22       Impact factor: 5.849

3.  The Goldilocks Window of Personalized Chemotherapy: Getting the Immune Response Just Right.

Authors:  Derek S Park; Mark Robertson-Tessi; Kimberly A Luddy; Philip K Maini; Michael B Bonsall; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2019-08-06       Impact factor: 12.701

4.  Preservation of Antigen-Specific Functions of αβ T Cells and B Cells Removed from Hematopoietic Stem Cell Transplants Suggests Their Use As an Alternative Cell Source for Advanced Manipulation and Adoptive Immunotherapy.

Authors:  Giuseppina Li Pira; Stefano Di Cecca; Simone Biagini; Elia Girolami; Elisabetta Cicchetti; Valentina Bertaina; Concetta Quintarelli; Ignazio Caruana; Barbarella Lucarelli; Pietro Merli; Daria Pagliara; Letizia Pomponia Brescia; Alice Bertaina; Mauro Montanari; Franco Locatelli
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

5.  Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression.

Authors:  Szilvia Bak; Sabine Tischer; Anna Dragon; Sarina Ravens; Lars Pape; Christian Koenecke; Mathias Oelke; Rainer Blasczyk; Britta Maecker-Kolhoff; Britta Eiz-Vesper
Journal:  Front Immunol       Date:  2018-12-17       Impact factor: 7.561

6.  G-CSF inhibits LFA-1-mediated CD4+ T cell functions by inhibiting Lck and ZAP-70.

Authors:  Shasha Zhao; Zhenyang Gu; Li Wang; Lixun Guan; Feiyan Wang; Nan Yang; Lan Luo; Zhe Gao; Yingwei Song; Lili Wang; Daihong Liu; Chunji Gao
Journal:  Oncotarget       Date:  2017-05-25

7.  Fever-Inspired Immunotherapy Based on Photothermal CpG Nanotherapeutics: The Critical Role of Mild Heat in Regulating Tumor Microenvironment.

Authors:  Yan Li; Lianghua He; Haiqing Dong; Yiqiong Liu; Kun Wang; Ang Li; Tianbin Ren; Donglu Shi; Yongyong Li
Journal:  Adv Sci (Weinh)       Date:  2018-03-25       Impact factor: 16.806

8.  G-CSF and G-CSFR Modulate CD4 and CD8 T Cell Responses to Promote Colon Tumor Growth and Are Potential Therapeutic Targets.

Authors:  Ioannis Karagiannidis; Stephanie J Jerman; Damian Jacenik; Brandon B Phinney; Ruoxin Yao; Eric R Prossnitz; Ellen J Beswick
Journal:  Front Immunol       Date:  2020-09-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.